Hajime. Kanda, et.al., MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity., The Journal of clinical investigation, 2006, 116

http://rdf.ncbi.nlm.nih.gov/pubmed/16691291

Hajime. Kanda, et.al., MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity., The Journal of clinical investigation, 2006, 116

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Tg(Fabp4-Ccl2)BYt
  http://metadb.riken.jp/db/mgi_rdf/MGI:4418675

class

http://purl.org/net/cito/citesAsAuthority

• Tg(Fabp4-Ccl2)BYt
  http://metadb.riken.jp/db/mgi_rdf/MGI:4418675

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• abnormal epididymal fat pad morphology_Lepr<db>/Lepr<db>
  http://metadb.riken.jp/0006319BKSCgDock7mLeprdbJclLeprdbLeprdbLeprdb
• decreased susceptibility to hepatic steatosis_Ccl2<tm1Rol>/Ccl2<tm1Rol>
  http://metadb.riken.jp/0002310B6129S4Ccl2tm1RolJCcl2tm1RolCcl2tm1RolCcl2tm1Rol
• abnormal epididymal fat pad morphology_Ccl2<tm1Rol>/Ccl2<tm1Rol>
  http://metadb.riken.jp/0006319B6129S4Ccl2tm1RolJCcl2tm1RolCcl2tm1RolCcl2tm1Rol
• increased circulating free fatty acid level_Tg(Fabp4-Ccl2)BYt/0
  http://metadb.riken.jp/0001554IC57BL6NTgFabp4Ccl2BYt0TgFabp4Ccl2BYt
• increased circulating glucose level_Tg(Fabp4-Ccl2)BYt/0
  http://metadb.riken.jp/0005559IC57BL6NTgFabp4Ccl2BYt0TgFabp4Ccl2BYt
• increased adiponectin level_Ccl2<tm1Rol>/Ccl2<tm1Rol>
  http://metadb.riken.jp/0004892B6129S4Ccl2tm1RolJCcl2tm1RolCcl2tm1RolCcl2tm1Rol
• decreased circulating free fatty acid level_Ccl2<tm1Rol>/Ccl2<tm1Rol>
  http://metadb.riken.jp/0002702B6129S4Ccl2tm1RolJCcl2tm1RolCcl2tm1RolCcl2tm1Rol
• improved glucose tolerance_Ccl2<tm1Rol>/Ccl2<tm1Rol>
  http://metadb.riken.jp/0005292B6129S4Ccl2tm1RolJCcl2tm1RolCcl2tm1RolCcl2tm1Rol
• increased insulin sensitivity_Ccl2<tm1Rol>/Ccl2<tm1Rol>
  http://metadb.riken.jp/0002891B6129S4Ccl2tm1RolJCcl2tm1RolCcl2tm1RolCcl2tm1Rol
• abnormal gluconeogenesis_Ccl2<tm1Rol>/Ccl2<tm1Rol>
  http://metadb.riken.jp/0003383B6129S4Ccl2tm1RolJCcl2tm1RolCcl2tm1RolCcl2tm1Rol
• decreased circulating insulin level_Ccl2<tm1Rol>/Ccl2<tm1Rol>
  http://metadb.riken.jp/0002727B6129S4Ccl2tm1RolJCcl2tm1RolCcl2tm1RolCcl2tm1Rol
• abnormal glucose homeostasis_Tg(Fabp4-Ccl2)BYt/0
  http://metadb.riken.jp/0002078IC57BL6NTgFabp4Ccl2BYt0TgFabp4Ccl2BYt
• increased liver triglyceride level_Tg(Fabp4-Ccl2)BYt/0
  http://metadb.riken.jp/0009355IC57BL6NTgFabp4Ccl2BYt0TgFabp4Ccl2BYt
• insulin resistance_Tg(Fabp4-Ccl2)BYt/0
  http://metadb.riken.jp/0005331IC57BL6NTgFabp4Ccl2BYt0TgFabp4Ccl2BYt
• abnormal epididymal fat pad morphology_Tg(Fabp4-Ccl2)BYt/0
  http://metadb.riken.jp/0006319IC57BL6NTgFabp4Ccl2BYt0TgFabp4Ccl2BYt
• abnormal gluconeogenesis_Tg(Fabp4-Ccl2)BYt/0
  http://metadb.riken.jp/0003383IC57BL6NTgFabp4Ccl2BYt0TgFabp4Ccl2BYt
• impaired glucose tolerance_Tg(Fabp4-Ccl2)BYt/0
  http://metadb.riken.jp/0005293IC57BL6NTgFabp4Ccl2BYt0TgFabp4Ccl2BYt
• decreased fat cell size_Ccl2<tm1Rol>/Ccl2<tm1Rol>
  http://metadb.riken.jp/0009269B6129S4Ccl2tm1RolJCcl2tm1RolCcl2tm1RolCcl2tm1Rol